Patients
MYELOMA
In this study, clinical data were collected from 58 nontransplant NDMM patients who were treated with a bortezomib-based three-drug regimen without lenalidomide followed by Rd or Vd as a continuous treatment in our hospital from 2017 to 2019. The diagnosis of MM was established following the criteria of the International Myeloma Working Group (IMWG) [